ICH stability testing for pharmaceutical drug substances or drug products with efficient study management, standard or bespoke storage conditions to meet your real-time, accelerated or forced degradation stability study requirements

ICH stability testing is an essential part of drug product development, in particular, supporting IND/NDA submission activities. Drug stability testing allows evaluation of active pharmaceutical ingredient (API) stability or drug product stability under the influence of a variety of environmental factors such as temperature, humidity and light. Data from these studies enable recommended storage conditions, retest intervals and shelf lives to be established.

Selecting an experienced stability study service partner who offers efficient study management, flexible storage conditions and testing capabilities which satisfy all regulatory criteria for your real-time stability testing, long-term, intermediate, accelerated stability studies, forced-degradation, photo-stability, in use or follow-up stability testing trial requirements is key to success. Stability testing can present significant analytical hurdles and specialised knowledge is required to develop and validate stability indicating methods and perform analysis of leachable substances which migrate from pharmaceutical packaging into the product.

With a network of ICH stability storage facilities in the UK, US and Australia, we offer an extensive capacity and a range of ich stability zones including climatic walk-in chambers, cabinets and refrigerated as well as freezer storage, covering all ICH stability storage conditions. These are fully controlled and monitored with back up chambers at each site. All ICH stability testing sites have 24-hour alarm systems with dedicated on call teams to react to the excursions from storage conditions. Our stability teams provide professionally managed Good Manufacturing Practice (cGMP) ICH stability studies conducted according to ICH stability guidelines such as ICH Q1A (R2). We are experienced across all dosage forms product types such as orally inhaled and nasal drug products (OINDP), biopharmaceuticals, consumer healthcare, medical devices or vaccines. We also offer stability storage outsourcing and stability contingency storage services to help you mitigate risks associated with costly stability trials.

GMP Stability Services:

  • cGMP registration stability programs
  • ICH stability protocol design and program management
  • Development and validation of stability indicating methods
  • Stability testing of active pharmaceutical ingredients and finished pharmaceutical products, clinical trial materials, formulated products
  • Tailored reporting (timepoint and final reports)
  • Temperature cycling, freeze-thaw study and shipping studies
  • Stability contingency storage
  • Stability storage outsourcing
  • Forced degradation testing 
  • Real time stability testing
  • Long term stability testing
  • Intermediate stability testing
  • Accelerated stability testing
  • In use stability testing
  • Follow-up stability trials
  • Formulation stability testing
  • Biologics stability studies
  • Specialist expertise for OINDP stability programs
  • Extractables / leachables

ICH Stability Storage Conditions

We have an extensive range of ICH stability storage conditions spanning the ICH climatic zones and also bespoke storage capabilities:

  • 21ºC / 45% RH
  • 25ºC / 40% RH
  • 25ºC / 60% RH
  • 30ºC / 25% RH
  • 30ºC / 35% RH
  • 30ºC / 65% RH
  • 30ºC / 75% RH
  • 40ºC / 75% RH
  • 40ºC / NMT 25%RH
  • Cabinets 50 ºC, 57 ºC, 60 ºC
  • Storage at 2-8ºC
  • ULT storage -20ºC, -40ºC, -80ºC
  • ICH Photostability (ICH Q1B Photostability Options 1 & 2)
  • Specialised conditions
  • Freeze/thaw temperature cycling tests

Stability Testing of Pharmaceutical Products
Stability testing can present significant analytical hurdles and specialised knowledge is required to develop and validate stability indicating assay methods and perform analysis of leachable substances which migrate from pharmaceutical packaging into the product. Following ICH stability testing guidelines, our analytical laboratory network provides development and validation of stability-indicating methods utilizing a range of technologies to identify and quantify degradation products. Routine time point testing includes the usual tests such as assay and impurity analysis, dissolution, moisture, hardness, friability and disintegration. Intertek’s scientists have specialist expertise in OINDP testing for stability including particle or droplet size to provide data to drive understanding of the delivered formulation and delivery of the drug from the inhalation device. Our know-how in extractables and leachables studies means that we can ensure that the product container/packaging system demonstrates sufficient stability over the relevant lifecycle of your product.

Your Pharmaceutical Stability Program Partner
With nearly 30 years’ experience in conducting stability studies integrated with a comprehensive understanding of the latest developments in regional, country and ICH guidelines for stability studies, we offer a truly flexible stability outsourcing partnership. With integrated storage and testing capability, our expertise allows you to focus on your core business objectives. Bringing quality and safety to life, we offer Total Quality Assurance expertise to help you to meet and exceed quality, safety and regulatory standards for your pharmaceutical products.

 

Related Links

The Inhaled and Nasal Biologics DNA forum logo in white and yellow font against a dark turquoise backgrouns

4th Annual Inhaled & Nasal Biologics | DNA Forum

25-25 September 2025 
Cambridge, UK 


Join us for a ground-breaking and insightful forum on inhaled and nasal biologics development: Two days of cutting-edge talks and networking opportunities with leaders in this complex area of inhaled medication and inhaled vaccine development.
LEARN MORE & REGISTER

Intertek Melbourn Laboratory

GMP Pharmaceutical Analysis and Formulation Expertise

Intertek Melbourn
Saxon Way, Melbourn
Herts, SG8 6DN 
UK

RECENT NEWS: Intertek partners with CrystecPharma to advance formulation science and accelerate development for dry powder inhalers

Intertek Pharmaceutical Services

P.O. Box 470
291 Route 22 East
Salem Industrial Park
Whitehouse, NJ 08888
USA

Submit a Sample

Sample Size and Pricing Guide (PDF)

Download our Pharmaceutical Testing brochure (PDF)

Download our Intertek Pharmaceutical Services Brochure

Download our Custom Extractables and Leachables Solutions Brochure

Contact Intertek